Chronic Idiopathic Constipation (CIC) Treatment Market Growth Analysis 2022-28

The global chronic idiopathic constipation treatment market size was valued at USD 8.2 billion in 2021 and is poised to grow at a significant CAGR of 7.2% during the forecast period 2022-28. Constipation is a disorder in which stool frequency drops to three times per week and stool passage becomes difficult. Constipation is a frequent functional gastrointestinal condition that can have a negative impact on a patient's life. The occurrence of persistent constipation problems with really no well-defined underlying issue is referred to as chronic idiopathic constipation. Irregular bowel motions, firm stools, straining during defecation, a sense of partial evacuation, bloating, and stomach pain, are all signs of chronic idiopathic constipation. Laboratory studies, endoscopy, radiographic examinations, magnetic resonance imaging, and physiological testing are used to identify chronic idiopathic constipation. For persistent idiopathic constipation, there are presently just a few authorized therapeutic options.